Back to Search
Start Over
Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
- Source :
-
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese [Hellenic J Cardiol] 2007 Mar-Apr; Vol. 48 (2), pp. 80-8. - Publication Year :
- 2007
-
Abstract
- Introduction: Levosimendan is a new inotropic vasodilator for the treatment of decompensated heart failure. Compared to other inotropic agents, it has been shown to improve myocardial contractility without increasing oxygen requirements. However, experience with levosimendan in patients with low cardiac output after cardiopulmonary bypass is limited. In this case series we present the short-term haemodynamic effects of levosimendan added to dobutamine for the management of low cardiac output syndrome after cardiac surgery.<br />Methods: Twelve patients with low cardiac output during the first 6 hours after completion of cardiopulmonary bypass, who were already receiving dobutamine at a mean dose of 6.7 microg/kg/min, were treated with levosimendan at a loading dose of 6 microg/kg, followed by a 24-hour infusion of 0.2 microg/kg/min. During a 24-hour observation period the following haemodynamic parameters were measured: arterial, central venous, pulmonary arterial and pulmonary capillary wedge pressure, heart rate, cardiac index, stroke volume, systemic and pulmonary vascular resistance, as well as mixed venous oxygen saturation, oxygen delivery and oxygen extraction ratio.<br />Results: Levosimendan significantly improved cardiac index (from 2.1 +/- 0.1 L/min/m2 at baseline to 3.2 +/- 0.3 L/min/m2 at 24 hrs, p < 0.001) as well as mixed venous oxygen saturation, oxygen delivery and oxygen extraction ratio (p < 0.001) and caused a significant reduction in systemic and pulmonary vascular resistance (p < 0.001). At the same time, a significant decrease in central venous, pulmonary arterial and pulmonary capillary wedge pressure was noted (p < 0.001). These beneficial haemodynamic effects resulted in significantly decreased catecholamine requirements.<br />Conclusions: In this group of cardiac surgical patients with postoperative myocardial dysfunction resistant to dobutamine, levosimendan added to dobutamine was effective in reversing low cardiac output syndrome.
- Subjects :
- Adrenergic beta-Agonists therapeutic use
Aged
Blood Pressure drug effects
Cardiac Output, Low etiology
Cardiopulmonary Bypass adverse effects
Catecholamines therapeutic use
Dobutamine therapeutic use
Drug Therapy, Combination
Female
Greece
Heart Diseases surgery
Heart Rate drug effects
Humans
Male
Middle Aged
Myocardial Contraction drug effects
Oxygen Consumption drug effects
Research Design
Simendan
Stroke Volume drug effects
Time Factors
Treatment Outcome
Vascular Resistance drug effects
Cardiac Output, Low drug therapy
Cardiac Output, Low physiopathology
Cardiac Surgical Procedures
Cardiotonic Agents therapeutic use
Hydrazones therapeutic use
Pyridazines therapeutic use
Vasodilator Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1109-9666
- Volume :
- 48
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
- Publication Type :
- Academic Journal
- Accession number :
- 17489345